Reports about: OFIX
Short OFIX. Orthofix to plunge 50% on undisclosed FDA issue and accounting manipulation
December 16, 2016
Summary Bone Growth Stimulators (“BGS”) comprise the largest segment of revenue and more than half of profits, while also driving growth at Orthofix. Other segments are lower margin, commodity businesses...